Free Trial

Finch Therapeutics Group Q2 2024 Earnings Report

Finch Therapeutics Group logo
$15.80 +0.05 (+0.32%)
As of 02/21/2025 03:36 PM Eastern

Finch Therapeutics Group EPS Results

Actual EPS
-$3.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Finch Therapeutics Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Finch Therapeutics Group Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Finch Therapeutics Group Earnings Headlines

Arquitos Capital Management Q4 2024 Commentary
Watch This Robotics Demo Before March 17th
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
Finch Therapeutics announces Nasdaq delisting, SEC deregistration
Finch Therapeutics Group to Delist from Nasdaq
See More Finch Therapeutics Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Finch Therapeutics Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Finch Therapeutics Group and other key companies, straight to your email.

About Finch Therapeutics Group

Finch Therapeutics Group (NASDAQ:FNCH), a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.

View Finch Therapeutics Group Profile

More Earnings Resources from MarketBeat